The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study

202154 citationsJournal Articlehybrid Open Access

Authors

The trial is registered at the US National Institutes of Health (ClinicalTrials.gov; NCT04397562).

Good health and well-being

Published in: Inflammation Research

Volume 70, Issue 10-12, pp. 1233-1246

Field-Weighted Citation Impact: 3.19